Abstract
Lipids are key regulators of immune responses. In this study we investigated the direct impact of oxidized phospholipids (ox-PL) on T cell activation and function. We could demonstrate that ox-PL strongly inhibit proliferation of purified human T cells induced with anti-CD3/CD28 or anti-CD3/CD63 mAb, whereas proliferation of naive T cells from human cord blood was not affected by ox-PL. Unoxidized phospholipids showed no such effect. Inhibition of T cell proliferation by ox-PL was not due to cell death. Moreover, T cell proliferation triggered by PMA/ionomycin activation was not diminished by ox-PL. T cells activated in the presence of ox-PL produced and released low amounts of IFN-gamma and IL-2, whereas IL-4 was only slightly diminished. Ox-PL prevented the expression of de novo synthesized activation markers (CD25, MHC class II) but not expression of CD63 or CD69. We further observed that T cells stimulated in the presence of ox-PL are poorly cytotoxic T cells. Most importantly, T cells activated in the presence of ox-PL failed to proliferate in response to restimulation. This hypo-proliferative state was accompanied with an up-regulation of early growth response gene 3 and Casitas B-lineage lymphoma protein B. Taken together, our results demonstrate that ox-PL are potent and specific regulators of T cell activation and function.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / pharmacology
-
Antigens, Differentiation, T-Lymphocyte / metabolism
-
CD3 Complex / immunology
-
Cell Differentiation / drug effects
-
Cell Differentiation / immunology
-
Cell Proliferation / drug effects*
-
Cells, Cultured
-
Clonal Anergy / drug effects*
-
Cytokines / metabolism
-
Cytotoxicity, Immunologic / drug effects
-
Early Growth Response Protein 3 / genetics
-
Gene Expression / drug effects
-
Histocompatibility Antigens Class II / metabolism
-
Humans
-
Lymphocyte Activation / drug effects
-
Oxidation-Reduction
-
Phosphatidylglycerols / chemistry
-
Phosphatidylglycerols / pharmacology
-
Phosphatidylserines / chemistry
-
Phosphatidylserines / pharmacology
-
Phospholipid Ethers / chemistry
-
Phospholipid Ethers / pharmacology
-
Phospholipids / chemistry
-
Phospholipids / pharmacology*
-
Proto-Oncogene Proteins c-cbl / genetics
-
T-Lymphocytes / cytology
-
T-Lymphocytes / drug effects*
-
T-Lymphocytes / metabolism
-
T-Lymphocytes, Cytotoxic / cytology
-
T-Lymphocytes, Cytotoxic / drug effects
-
T-Lymphocytes, Cytotoxic / metabolism
Substances
-
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine
-
1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine
-
Antibodies, Monoclonal
-
Antigens, Differentiation, T-Lymphocyte
-
CD3 Complex
-
Cytokines
-
EGR3 protein, human
-
Histocompatibility Antigens Class II
-
Phosphatidylglycerols
-
Phosphatidylserines
-
Phospholipid Ethers
-
Phospholipids
-
Early Growth Response Protein 3
-
Proto-Oncogene Proteins c-cbl